Anzai, Haruka
Miwa, Chihiro
Ogasawara, Sadahisa https://orcid.org/0000-0002-6540-9064
Fujiya, Makoto
Kurosaki, Hiroki
Tsuchiya, Takahiro
Yoshino, Ryohei
Katayama, Keiichi
Sawada, Midori
Akatsuka, Teppei
Izai, Ryo
Yonemoto, Takuya
Yumita, Sae
Koroki, Keisuke
Inoue, Masanori
Nakamura, Masato
Kanogawa, Naoya
Nakamoto, Shingo
Makishima, Hirokazu
Shinoto, Makoto
Wakatsuki, Masaru
Yamada, Shigeru
Ishikawa, Hitoshi
Kato, Jun
Article History
Received: 18 July 2025
Accepted: 3 December 2025
First Online: 12 January 2026
Declarations
:
: Sadahisa Ogasawara received honoraria from Eli Lilly (Indianapolis, IN, USA), AstraZeneca (Cambridge, UK), and research grants from Bayer(Leverkusen, Germany), AstraZeneca, Eisai(Tokyo, Japan), Chugai Pharma(Tokyo, Japan). The other authors have no conflicts of interest to declare.
: This reseearch was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. Written informed consent for publication of the case details and accompanying images was obtained from all patients.